Harvard Bioscience (HBIO) Current Deferred Revenue (2010 - 2026)
Harvard Bioscience (HBIO) reported Current Deferred Revenue of $3.8 million for Q1 2026, up 10.42% year-over-year from $3.4 million in Q1 2025, and up 9.78% on a QoQ basis from $3.4 million in Q4 2025.
Harvard Bioscience (HBIO) has 17 years of Current Deferred Revenue data on file, last reported at $3.8 million in Q1 2026.
- Quarterly Current Deferred Revenue rose 10.42% year-over-year to $3.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.8 million (up 10.42% YoY) and the FY2025 annual result came in at $3.4 million, down 9.43% from the prior year.
- Current Deferred Revenue grew to $3.8 million in Q1 2026 per HBIO's latest filing, from $3.4 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $4.5 million in Q4 2023 and bottomed at $3.2 million in Q3 2025.
- The 5-year median for Current Deferred Revenue is $3.8 million (2026), against an average of $3.8 million.
- The widest annual swing landed in 2023, when Current Deferred Revenue soared 33.77%; it then slipped 21.9% in 2025.
- Tracing HBIO's Current Deferred Revenue over 5 years: stood at $3.4 million in 2022, then jumped by 33.77% to $4.5 million in 2023, then retreated by 15.57% to $3.8 million in 2024, then fell by 9.43% to $3.4 million in 2025, then grew by 9.78% to $3.8 million in 2026.
- Per Business Quant, the three latest HBIO Current Deferred Revenue figures stand at $3.8 million (Q1 2026), $3.4 million (Q4 2025), and $3.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.78 Mn |
| Dec 31, 2025 | 3.45 Mn |
| Sep 30, 2025 | 3.17 Mn |
| Jun 30, 2025 | 3.40 Mn |
| Mar 31, 2025 | 3.43 Mn |
| Dec 31, 2024 | 3.81 Mn |
| Sep 30, 2024 | 3.69 Mn |
| Jun 30, 2024 | 4.01 Mn |
| Mar 31, 2024 | 4.39 Mn |
| Dec 31, 2023 | 4.51 Mn |
| Sep 30, 2023 | 4.01 Mn |
| Jun 30, 2023 | 3.84 Mn |
| Mar 31, 2023 | 4.12 Mn |
| Dec 31, 2022 | 3.37 Mn |
| Sep 30, 2022 | 3.64 Mn |
| Jun 30, 2022 | 3.61 Mn |
| Mar 31, 2022 | 3.96 Mn |
| Dec 31, 2021 | 4.27 Mn |
| Sep 30, 2021 | 3.62 Mn |
| Jun 30, 2021 | 3.68 Mn |
| Mar 31, 2021 | 3.64 Mn |
| Dec 31, 2020 | 3.77 Mn |
| Sep 30, 2020 | 3.56 Mn |
| Jun 30, 2020 | 3.65 Mn |
| Mar 31, 2020 | 3.67 Mn |
| Dec 31, 2019 | 3.95 Mn |
| Sep 30, 2019 | 3.60 Mn |
| Jun 30, 2019 | 3.53 Mn |
| Mar 31, 2019 | 3.72 Mn |
| Dec 31, 2018 | 3.82 Mn |
| Sep 30, 2018 | 3.27 Mn |
| Jun 30, 2018 | 3.55 Mn |
| Mar 31, 2018 | 3.85 Mn |
| Dec 31, 2017 | 505,000.00 |
| Sep 30, 2017 | 633,000.00 |
| Jun 30, 2017 | 546,000.00 |
| Mar 31, 2017 | 598,000.00 |
| Dec 31, 2016 | 500,000.00 |
| Sep 30, 2016 | 729,000.00 |
| Jun 30, 2016 | 913,000.00 |
| Mar 31, 2016 | 783,000.00 |
| Dec 31, 2015 | 752,000.00 |
| Sep 30, 2015 | 795,000.00 |
| Jun 30, 2015 | 864,000.00 |
| Mar 31, 2015 | 980,000.00 |
| Dec 31, 2014 | 655,000.00 |
| Sep 30, 2014 | 592,000.00 |
| Jun 30, 2014 | 609,000.00 |
| Mar 31, 2014 | 613,000.00 |
| Dec 31, 2013 | 640,000.00 |
| Sep 30, 2013 | 632,000.00 |
| Jun 30, 2013 | 740,000.00 |
| Mar 31, 2013 | 586,000.00 |
| Dec 31, 2012 | 482,000.00 |
| Sep 30, 2012 | 585,000.00 |
| Jun 30, 2012 | 570,000.00 |
| Mar 31, 2012 | 638,000.00 |
| Dec 31, 2011 | 483,000.00 |
| Sep 30, 2011 | 360,000.00 |
| Jun 30, 2011 | 497,000.00 |
| Dec 31, 2010 | 451,000.00 |